OPPORTUNISTIC INFECTIONS IN INFLAMMATORY BOWEL DISEASE: CYTOMEGALOVIRUS - CLINICAL OBSERVATION


Cite item

Full Text

Abstract

The article presents a case of ulcerative colitis complicated by generalized cytomegalovirus (CMV) infection in woman 48 years old. Infection has developed due to immunosuppressive therapy against the background of disease-associated immunodeficiency. Diagnosis was made just posthumously: morphologic study of autopsy revealed a typical owl's eye cells in the tissues of rectum, lung, brain, thyroid gland. Polymerase chain reaction confirmed the presence of CMV DNA in tissues of the rectum, lung, and brain.

References

  1. Stallmach A, Carstens O. Rolе of infections in the manifestation or reactivation of inflammatory bowel diseases. IBD 2002;8:213-18.
  2. Seow СН, De Silva S, Kaplan GG, et al. Managing the Risks of IBD Therapy. Current Gastroenterology Reports 2009;11:509-17.Reinisch W. ECCO Guidelines on the Management of Opportunistic Infections in IBD. Oral presentation, Moscow 2009.
  3. Winther KV, et al. Gastroenterology 2003. Winther KV, Jess T, Langholz E. Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. Gastroenterology 2003;125(6):1576-82.
  4. Jess T, et al. Gastroenterology 2002. Jess T, Winther KV, Munkholm P, et al. Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterology 2002; 122:1808.
  5. Cosnes, Gut 2005. Cosnes J, Nion-Larmurier I, Beaugerie L. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005;54(2):237-41.
  6. Juillerat P, Pettet V, Froehlich F, et al. SWISS IBD cohort study (SIBDCS): preliminary results from physician enrollment questionnaries. JCC 2008;2(1):abstr. P230.
  7. Rahiar JF, Ben-Horin S, Chowers Y, et al. European evidence based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. JCC 2009;3(2):47-140.
  8. Arts J, D'Haens G, Zeegers M, et al. Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis. Inflamm Bowel Dis 2004;10:73-78.
  9. ACT I, ACT II 2005.
  10. ACCENT I, ACCENT II 2004.
  11. Goodgame RW. Gastrointestinal Cytomegalovirus Disease. Ann Int Med 2010;156(6).
  12. Hommers DW, Sterringa G, van Deventer SJ, et al. The pathogenecity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. IBD 2004;10(3):245-50.
  13. Pollok RC. Viruses causing in AIDS. Novartis Found Symp 2001;238:276-83.
  14. Buckner FS, Pomeroy C. Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS. Clin Infect Dis 1993;17(4):644-56.
  15. Criscuoli V, Rizzuto MR, Cottome M. Cytomegalovirus and inflammatory bowel disease: is there a link? World J Gastroenterol 2006;12(30);4813-18.
  16. Papadakis KA, Tung JK, Binder SW, et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001;96(7):2137-42.
  17. Taruner M, Loftus EV, Harmsen WS, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008; 13494:929-36.
  18. Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol 2006;101(12):2857-65.
  19. Ayre K, Warren B, Jeffery K, et al. The role of CMV in steroid-resistant ulcerative colitis: a systematic review. JCC 2009;3(3):141-48.
  20. Subramanian V, Finlayson C, Harrison T, et al. Primary cytomegalovirus infectious colitis complicating Crohn's disease successfully treated with oral vanganciclovir. JCC 2010;4:199-202.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Bionika Media